128 related articles for article (PubMed ID: 12213473)
1. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist.
Meltzer PC; Liu S; Blanchette H; Blundell P; Madras BK
Bioorg Med Chem; 2002 Nov; 10(11):3583-91. PubMed ID: 12213473
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 6- and 7- hydroxy-8-azabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.
Meltzer PC; Wang B; Chen Z; Blundell P; Jayaraman M; Gonzalez MD; George C; Madras BK
J Med Chem; 2001 Aug; 44(16):2619-35. PubMed ID: 11472216
[TBL] [Abstract][Full Text] [Related]
4. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
5. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.
Enyedy IJ; Sakamuri S; Zaman WA; Johnson KM; Wang S
Bioorg Med Chem Lett; 2003 Feb; 13(3):513-7. PubMed ID: 12565962
[TBL] [Abstract][Full Text] [Related]
7. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
Desai RI; Kopajtic TA; Koffarnus M; Newman AH; Katz JL
J Neurosci; 2005 Feb; 25(8):1889-93. PubMed ID: 15728828
[TBL] [Abstract][Full Text] [Related]
8. 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors.
Sakamuri S; Enyedy IJ; Zaman WA; Tella SR; Kozikowski AP; Flippen-Anderson JL; Farkas T; Johnson KM; Wang S
Bioorg Med Chem; 2003 Mar; 11(6):1123-36. PubMed ID: 12614900
[TBL] [Abstract][Full Text] [Related]
9. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
10. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
11. Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists.
Slusher BS; Tiffany CW; Olkowski JL; Jackson PF
Drug Alcohol Depend; 1997 Oct; 48(1):43-50. PubMed ID: 9330920
[TBL] [Abstract][Full Text] [Related]
12. 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters.
Meltzer PC; Blundell P; Yong YF; Chen Z; George C; Gonzalez MD; Madras BK
J Med Chem; 2000 Aug; 43(16):2982-91. PubMed ID: 10956207
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies.
Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Deschaux O; Bandyopadhyay BC; Tella SR; Zaman WA; Johnson KM
J Med Chem; 2000 Feb; 43(3):351-60. PubMed ID: 10669562
[TBL] [Abstract][Full Text] [Related]
14. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
15. Rational design and synthesis of novel 2,5-disubstituted cis- and trans-piperidine derivatives exhibiting differential activity for the dopamine transporter.
Dutta AK; Davis MC; Reith ME
Bioorg Med Chem Lett; 2001 Sep; 11(17):2337-40. PubMed ID: 11527726
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.
Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
J Med Chem; 2000 Jan; 43(2):205-13. PubMed ID: 10649976
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling, structure--activity relationships and functional antagonism studies of 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketones as a novel class of dopamine transporter inhibitors.
Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Zaman WA; Johnson KM
Bioorg Med Chem; 2001 Jul; 9(7):1753-64. PubMed ID: 11425577
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
19. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
Uhl G; Lin Z; Metzger T; Dar DE
Methods Enzymol; 1998; 296():456-65. PubMed ID: 9779467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
